Document is current
Any future updates will be listed below
-
Authors
Luk-In, Sirirat
Leepiyasakulchai, Chaniya
Saelee, Chutiphon
Keeratichamroen, Arisa
Srisangwan, Nuttarat
Ponprachanuvut, Punnee
Chammari, Kantanit
Chatsuwan, Tanittha
Wannigama, Dhammika Leshan
Shein, Aye Mya Sithu
Kueakulpattana, Naris
Srisakul, Sukrit
Sranacharoenpong, Kitti
-
Funding
Funding for this research was provided by:
National Innovation Agency (CE112-01-65-05-0127)
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 8 November 2024
First Online: 14 November 2024
Declarations
:
: The authors declare no competing interests.
: This study was conducted in accordance with the International Guidelines for Human Research Protection, including the Declaration of Helsinki, The Belmont Report, CIOMS Guidelines and the International Conference on Harmonization in Good Clinical Practice (ICH-GCP). The study protocol was approved by Mahidol University’s Central Institutional Review Board (Protocol No. MU-CIRB 2022/300.0711 and COA No. MU-CIRB 2023/004.0901). This study is registered in the NIH’s Protocol Registration and Results System (PRS) on their website (ClinicalTrials.gov ID: NCT06274242). All subjects provided written informed consent in compliance with the MU-CIRB informed consent guidelines.
